Estamos teniendo problemas temporales. Actualmente los datos de mercado de esta página se están retrasando. Ten paciencia mientras lo solucionamos y restauramos tus listas personalizadas.

Mercados españoles cerrados en 29 mins
  • PR Newswire

    Max Stock Limited Reports General Meeting Results

    Max Stock Limited (TASE: MAXO) (the "Company") today held a general meeting of its shareholders and reported that all of the agenda items had been approved with the required majorities, as follows:

  • PR Newswire

    Children's Hospital of Philadelphia Researchers Find Some Patients with Aicardi Goutières Syndrome Have Normal IQ

    In a landmark study, researchers from Children's Hospital of Philadelphia (CHOP) found that two separate objective assessment tools and nonverbal measurements of IQ can help assess cognitive function in children with Aicardi Goutières Syndrome (AGS), allowing treatment teams to provide appropriate support and interventions. The findings were recently published in the journal Neurology.

  • GlobeNewswire

    CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change

    HOUSTON, June 26, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is thrilled to introduce the groundbreaking strategies formulated by its freshly appointed Treasurer and Director, Mr. John Jones, who has facilitated a series of insightful discussions and established official communications between CBIH and a pioneering company in innovative product and packaging solutions for globally recognized brands. As CBIH prepares for the manufacturing and distribution

  • GlobeNewswire

    Innovative Maintenance and Repair Solutions Sought for Shipyard Technology Exhibition

    NCMS and Puget Sound Naval Shipyard to welcome technology innovators Ship Maintenance at Puget Sound Naval Shipyard & Intermediate Maintenance Facility Puget Sound Naval shipyard and Intermediate Maintenance Facility Detachment Everett and Northwest Regional Maintenance Center team say farewell to the USS CHOSIN (CG 65) (US NAVY Photo by Wendy Hallmark.) Ann Arbor, MI, June 26, 2024 (GLOBE NEWSWIRE) -- The National Center for Manufacturing Sciences (NCMS) in partnership with Puget Sound Naval Sh

  • GlobeNewswire

    Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss

    Bagsværd, Denmark, 26 June 2024 – Novo Nordisk today announced that the CLARION-CKD phase 3 trial failed to meet its primary endpoint and that it will recognise an impairment loss of around DKK 5.7 billion related to the intangible asset ocedurenone in the second quarter of 2024. Novo Nordisk acquired ocedurenone from KBP Biosciences PTE., Ltd. in 2023. The phase 3 lead indication trial CLARION-CKD, which investigated ocedurenone in patients with uncontrolled hypertension and advanced chronic ki

  • Investor's Business Daily

    Amazon Gets Price-Target Hike From Analyst On 'Runway' For More Retail Efficiency

    Analyst with Bank of America believe Amazon has "runway ahead" to further improve the efficiency of its retail operations.

  • PR Newswire

    City of Reno Launches DROPS Mobile App to Revolutionize Unsheltered Outreach Efforts

    The City of Reno, in collaboration with ServiceNow and NewRocket, proudly announces the launch of DROPS (Direct Resource Outreach & Placement Service), a groundbreaking mobile application designed to transform the way outreach workers assist unsheltered individuals. Reno Mayor Hillary Schieve highlighted the impact of this initiative: "DROPS is a game-changer for our city. By empowering our outreach team with this innovative technology, we are taking a major step forward in our efforts to tackle

  • Yahoo Finance Video

    Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst

    Novo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as their approval in China. While these names have been often cited as top picks in the pharmaceutical industry, are there hidden gems to look out for or do Eli Lilly and Novo Nordisk remain at the top of the class? Mizuho Healthcare Equity Strategist Jared Holz joins Morning Brief to give insight into the healthcare sector and what investors should keep in mind moving forward. "I think for me, Novo and Lilly are still going to be the top two. You know, as long as they are dominating in this kind of section of the market, it's really tough to not ride these a little bit longer, as far as other players in the GLP one market that might emerge that are of interest or intrigue to investors," Holz says. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Nicholas Jacobino Follow Yahoo Finance's latest coverage on Eli Lilly and Novo Nordisk, weight-loss drugs, and the pharmaceutical industry as a whole: How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs Eli Lilly seeks to expand Zepbound use to treat sleep apnea Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market Why the GLP-1 impact on other industries 'will take years' Eli Lilly unveils new manufacturing plant for GLP-1 pens Novo Nordisk to invest $4.1B in NC facility for GLP-1 drugs Eli Lilly's new Alzheimer's treatment could 'lift' drug market Novo Nordisk stock rises on Wegovy approval in China

  • CNW Group

    Helping communities prevent and reduce substance use-related harms among youth

    No community in Canada has been left untouched by substance use-related harms and the toxic illegal drug supply and overdose crisis. Efforts to prevent substance use, especially among youth, are critical and this means reaching out to young people who may be struggling with targeted support in their communities.

  • Business Wire

    RWS’s Linguistic AI Solution EVOLVE Wins Prestigious 2024 AI Breakthrough Award

    CHALFONT ST PETER, England, June 26, 2024--RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces that its linguistic AI solution, Evolve, has been awarded the ‘Machine Translation Innovation Award’ at the 2024 AI Breakthrough Awards.